Jefferies Maintains a 'Buy' on Array BioPharma (ARRY); Narrowing Loss; Phase 2 Data Driving Further Upside
Go back to Jefferies Maintains a 'Buy' on Array BioPharma (ARRY); Narrowing Loss; Phase 2 Data Driving Further Upside| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 5.05 -0.12 (2.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.17 | 52 Week High | $7.27 | |||
| Open | $5.15 | 52 Week Low | $2.39 | |||
| Day High | $5.29 | P/E | N/A | |||
| Day Low | $5.05 | EPS | $-0.61 | |||
| Volume | 7,042,112 | |||||
